BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12648456)

  • 61. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.
    Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS
    J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinct functional lineages of human V(alpha)24 natural killer T cells.
    Lee PT; Benlagha K; Teyton L; Bendelac A
    J Exp Med; 2002 Mar; 195(5):637-41. PubMed ID: 11877486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
    Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
    J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.
    Eberl G; Lowin-Kropf B; MacDonald HR
    J Immunol; 1999 Oct; 163(8):4091-4. PubMed ID: 10510341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.
    Hansen DS; Bernard NJ; Nie CQ; Schofield L
    J Immunol; 2007 May; 178(9):5779-88. PubMed ID: 17442962
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
    Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
    J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.
    Mempel M; Ronet C; Suarez F; Gilleron M; Puzo G; Van Kaer L; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2002 Jan; 168(1):365-71. PubMed ID: 11751982
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
    Burdin N; Brossay L; Kronenberg M
    Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
    Baron JL; Gardiner L; Nishimura S; Shinkai K; Locksley R; Ganem D
    Immunity; 2002 Apr; 16(4):583-94. PubMed ID: 11970881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.
    Duarte N; Stenström M; Campino S; Bergman ML; Lundholm M; Holmberg D; Cardell SL
    J Immunol; 2004 Sep; 173(5):3112-8. PubMed ID: 15322171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
    Matsuda JL; Naidenko OV; Gapin L; Nakayama T; Taniguchi M; Wang CR; Koezuka Y; Kronenberg M
    J Exp Med; 2000 Sep; 192(5):741-54. PubMed ID: 10974039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice.
    Sfondrini L; Besusso D; Zoia MT; Rodolfo M; Invernizzi AM; Taniguchi M; Nakayama T; Colombo MP; Ménard S; Balsari A
    J Immunol; 2002 Jul; 169(1):151-8. PubMed ID: 12077240
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses.
    Brown DR; Fowell DJ; Corry DB; Wynn TA; Moskowitz NH; Cheever AW; Locksley RM; Reiner SL
    J Exp Med; 1996 Oct; 184(4):1295-304. PubMed ID: 8879201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
    Lisbonne M; Diem S; de Castro Keller A; Lefort J; Araujo LM; Hachem P; Fourneau JM; Sidobre S; Kronenberg M; Taniguchi M; Van Endert P; Dy M; Askenase P; Russo M; Vargaftig BB; Herbelin A; Leite-de-Moraes MC
    J Immunol; 2003 Aug; 171(4):1637-41. PubMed ID: 12902459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells.
    Elewaut D; Shaikh RB; Hammond KJ; De Winter H; Leishman AJ; Sidobre S; Turovskaya O; Prigozy TI; Ma L; Banks TA; Lo D; Ware CF; Cheroutre H; Kronenberg M
    J Exp Med; 2003 Jun; 197(12):1623-33. PubMed ID: 12810685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.